Community Letter Urging Inclusion of Clinical Trial Provisions in Cures 2.0

In response to a request from Reps. Upton and DeGette for ideas to include in Cures 2.0 legislation, ACS CAN and six other organization urged the representatives to consider the recommendations for overcoming barriers to clinical trial participation published as part of a recent landscape report. The Cures 2.0 legislation is intended to remove barriers to access to innovative therapies.